TCL-275 Updated Results of an Investigator-Initiated Phase II Study of Pembrolizumab and Romidepsin for Patients With Relapsed or Refractory T-Cell Lymphoma (TCL) With Survival Analysis
Clinical Lymphoma Myeloma and Leukemia（2023）
关键词
TCL,T-cell lymphoma,checkpoint blockade,histone deacetylase inhibitor,T follicular helper type lymphoma,immunotherapy,phase II
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要